Cargando…
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is an incurable disease, caused by the mutations in the DMD gene, encoding dystrophin, an actin-binding cytoskeletal protein. Lack of functional dystrophin results in muscle weakness, degeneration, and as an outcome cardiac and respiratory failure. As th...
Autores principales: | Mucha, Olga, Podkalicka, Paulina, Kaziród, Katarzyna, Samborowska, Emilia, Dulak, Józef, Łoboda, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414747/ https://www.ncbi.nlm.nih.gov/pubmed/34479633 http://dx.doi.org/10.1186/s13395-021-00276-3 |
Ejemplares similares
-
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
por: Mucha, Olga, et al.
Publicado: (2021) -
miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2022) -
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2021) -
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
por: Kaziród, Katarzyna, et al.
Publicado: (2022)